0001127602-22-006288.txt : 20220223
0001127602-22-006288.hdr.sgml : 20220223
20220223162509
ACCESSION NUMBER: 0001127602-22-006288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220221
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finke Daniel P
CENTRAL INDEX KEY: 0001844305
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 22664094
MAIL ADDRESS:
STREET 1: ONE CVS DRIVE
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-21
0000064803
CVS HEALTH Corp
CVS
0001844305
Finke Daniel P
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
EVP/Pres, Health Care Benefits
Common Stock
2022-02-21
4
A
0
34387
0
A
57713.9607
D
Common Stock (pep)
3097.8084
D
Common Stock (restricted)
25701
D
Stock Option
54.19
2020-04-01
2029-04-01
Common Stock
32322
32322
D
Stock Option
58.34
2021-04-01
2030-04-01
Common Stock
54332
54332
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
82066
82066
D
Stock Option
52.37
2022-05-31
2029-05-31
Common Stock
28640
28640
D
Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
Option became exercisable in four equal annual installments, beginning on 4/1/2020.
Option became exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal installments, commencing 4/1/2022.
Option becomes exercisable in three equal installments, commencing 5/31/2022.
/s/ Daniel P. Finke
2022-02-23